Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,293Revenue (TTM) $M1,573Net Margin (%)64.3Altman Z-Score13.0
Enterprise Value $M4,349EPS (TTM) $20.6Operating Margin %75.7Piotroski F-Score8
P/E(ttm)5.9Beneish M-Score-1.6Pre-tax Margin (%)98.1Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %--Quick Ratio4.2Cash flow > EarningsN
Price/Sales3.85-y EBITDA Growth Rate %36.3Current Ratio4.5Lower Leverage y-yY
Price/Free Cash Flow14.1y-y EBITDA Growth Rate %410ROA % (ttm)48.3Higher Current Ratio y-yY
Dividend Yield %--PEG0.2ROE % (ttm)66.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M43.5ROIC % (ttm)114Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRDavid Dreman 2016-06-30 Add0.17%$98.33 - $121.03
($111.54)
$ 121.769%Add 2036.00%2,670
UTHRJoel Greenblatt 2016-06-30 Add0.01%$98.33 - $121.03
($111.54)
$ 121.769%Add 1.24%367,075
UTHRJoel Greenblatt 2016-03-31 Add0.04%$108.47 - $156.61
($127.11)
$ 121.76-4%Add 10.43%362,565
UTHRGeorge Soros 2016-03-31 Sold Out -0.01%$108.47 - $156.61
($127.11)
$ 121.76-4%Sold Out0
UTHRDavid Dreman 2016-03-31 Buy $108.47 - $156.61
($127.11)
$ 121.76-4%New holding125
UTHRKen Fisher 2016-03-31 Reduce$108.47 - $156.61
($127.11)
$ 121.76-4%Reduce -1.43%3,092
UTHRFirst Eagle Investment 2015-12-31 Sold Out -0.18%$119.57 - $160.91
($146.21)
$ 121.76-17%Sold Out0
UTHRJoel Greenblatt 2015-12-31 Add0.05%$119.57 - $160.91
($146.21)
$ 121.76-17%Add 9.00%328,310
UTHRGeorge Soros 2015-12-31 Buy 0.01%$119.57 - $160.91
($146.21)
$ 121.76-17%New holding4,400
UTHRKen Fisher 2015-12-31 Add$119.57 - $160.91
($145.83)
$ 121.76-17%Add 7.51%3,137
UTHRJoel Greenblatt 2015-09-30 Add0.05%$131.24 - $179.15
($160.64)
$ 121.76-24%Add 15.35%301,205
UTHRFirst Eagle Investment 2015-09-30 Add0.04%$131.24 - $179.15
($160.64)
$ 121.76-24%Add 28.56%548,807
UTHRKen Fisher 2015-09-30 Add$131.24 - $179.15
($160.64)
$ 121.76-24%Add 19.10%2,918
UTHRJoel Greenblatt 2015-06-30 Reduce-0.04%$159.69 - $188.56
($179.77)
$ 121.76-32%Reduce -10.29%261,125
UTHRFirst Eagle Investment 2015-06-30 Add0.02%$159.69 - $188.56
($179.77)
$ 121.76-32%Add 14.57%426,880
UTHRJoel Greenblatt 2015-03-31 Reduce-0.03%$124.93 - $179.51
($152.45)
$ 121.76-20%Reduce -9.91%291,077
UTHRFirst Eagle Investment 2015-03-31 Add$124.93 - $179.51
($152.45)
$ 121.76-20%Add 3.44%372,580
UTHRKen Fisher 2015-03-31 Buy $124.93 - $179.51
($152.45)
$ 121.76-20%New holding2,450
UTHRFirst Eagle Investment 2014-12-31 Add0.03%$122.11 - $134.8
($128.83)
$ 121.76-5%Add 37.43%360,180
UTHRJoel Greenblatt 2014-09-30 Reduce-0.4%$86.44 - $136.16
($102.87)
$ 121.7618%Reduce -55.36%288,401
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these investors:


News about UTHR:

Articles On GuruFocus.com
These Five Stocks Show a Combination of Value and Growth Aug 03 2016 
Worst Performance YTD: MasterCard, Lazard Aug 03 2016 
5 Mid-Cap Stocks With Low Enterprise Multiples Aug 03 2016 
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? Jul 01 2016 
Gurus Invest in Top Biotechnology Stocks Jun 20 2016 
United Therapeutics Is a Value Investor's Biotech Dream Apr 28 2016 
Cummins and Deckers are Candidates for a January Bounce Nov 20 2015 
Estimated Revenue Up 5% Stock Screen Nov 18 2015 
FDA Approval Of Cancer Drug Catapults United Therapeutics Shares By 2% Mar 11 2015 
Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. Oct 12 2014 

More From Other Websites
United Therapeutics Hurt By Competitive Pressure Aug 22 2016
United Therapeutics Corporation To Present At The 2016 Wedbush PacGrow Healthcare Conference Aug 10 2016
ETF’s with exposure to United Therapeutics Corp. : August 5, 2016 Aug 05 2016
United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016 Aug 04 2016
These Five Stocks Show a Combination of Value and Growth Aug 03 2016
Worst Performance YTD: MasterCard, Lazard Aug 03 2016
5 Mid-Cap Stocks With Low Enterprise Multiples Aug 03 2016
UNITED THERAPEUTICS CORP Financials Aug 03 2016
Inside Amgen’s Analyst Recommendations for 2016 Aug 03 2016
4 Biotech Stocks With Up to 300% Upside Potential and Upcoming Catalysts Aug 03 2016
United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today Jul 28 2016
Q2 2016 United Therapeutics Corp Earnings Release - Before Market Open Jul 28 2016
United Therapeutics tops Street 2Q forecasts Jul 28 2016
United Therapeutics tops Street 2Q forecasts Jul 28 2016
United Therapeutics Corporation Reports Second Quarter 2016 Financial Results Jul 28 2016
UNITED THERAPEUTICS CORP Files SEC form 10-Q, Quarterly Report Jul 28 2016
UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition Jul 28 2016
United Therapeutics Corporation Reports Second Quarter 2016 Financial Results Jul 28 2016
What Do Analysts Recommend for United Therapeutics? Jul 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)